Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$89,088
in 5 filings, $89K under 10b5-1 plans

Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-03-15 Glucksmann Alexandra Chief Operating Officer Exercise or conversion +1,000 $0.65 $650 118,788
2017-03-15 Glucksmann Alexandra Chief Operating Officer Sale −1,000 $26.41 $26K 117,788
2017-03-15 Glucksmann Alexandra Chief Operating Officer Exercise or conversion · Stock Option (right to buy) −1,000 30,461
2017-02-15 Glucksmann Alexandra Chief Operating Officer Exercise or conversion +6,000 $0.65 $4K 123,788
2017-02-15 Glucksmann Alexandra Chief Operating Officer Sale −5,000 $20.00 $100K 118,788
2017-02-15 Glucksmann Alexandra Chief Operating Officer Sale −1,000 $23.48 $23K 117,788
2017-02-15 Glucksmann Alexandra Chief Operating Officer Exercise or conversion · Stock Option (right to buy) −6,000 31,461
2016-08-23 Glucksmann Alexandra Chief Operating Officer Exercise or conversion +1,000 $0.65 $650 118,788
2016-08-23 Glucksmann Alexandra Chief Operating Officer Sale −1,000 $20.00 $20K 117,788
2016-08-23 Glucksmann Alexandra Chief Operating Officer Exercise or conversion · Stock Option (right to buy) −1,000 37,461

Page 1 of 1 · 10 trades